These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27939112)

  • 1. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires.
    Li J; Feng Y; Han J; Fan B; Wu D; Zhang D; Du D; Li H; Lim J; Wang J; Jin Y; Fu Z
    Pain Physician; 2012; 15(2):179-86. PubMed ID: 22430656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
    Barbosa M; Bennett MI; Verissimo R; Carvalho D
    Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
    Garoushi S; Johnson MI; Tashani OA
    Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
    Hamdan A; Luna JD; Del Pozo E; Gálvez R
    Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
    Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
    Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linguistic adaptation into Spanish and psychometric validation of the ID-Pain questionnaire for the screening of neuropathic pain].
    Gálvez R; Pardo A; Cerón JM; Villasante F; Aranguren JL; Saldaña MT; Navarro A; Ruiz MA; Díaz S; Rejas J
    Med Clin (Barc); 2008 Nov; 131(15):572-8. PubMed ID: 19080838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural adaptation and validation of the painDETECT scale into Spanish.
    De Andrés J; Pérez-Cajaraville J; Lopez-Alarcón MD; López-Millán JM; Margarit C; Rodrigo-Royo MD; Franco-Gay ML; Abejón D; Ruiz MA; López-Gomez V; Pérez M
    Clin J Pain; 2012; 28(3):243-53. PubMed ID: 21926908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting.
    Isomura T; Sumitani M; Matsudaira K; Kawaguchi M; Inoue R; Hozumi J; Tanaka T; Oshima H; Mori K; Taketomi S; Inui H; Tahara K; Yamagami R; Hayakawa K
    Pain Pract; 2017 Jul; 17(6):800-807. PubMed ID: 27770598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.
    Alkan H; Ardic F; Erdogan C; Sahin F; Sarsan A; Findikoglu G
    Pain Med; 2013 Dec; 14(12):1933-43. PubMed ID: 23924395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
    Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
    Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
    Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
    Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain].
    Pérez C; Gálvez R; Insausti J; Bennett M; Ruiz M; Rejas J;
    Med Clin (Barc); 2006 Oct; 127(13):485-91. PubMed ID: 17043002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.
    Yurdakul OV; Rezvani A; Kucukakkas O; Tolu S; Kilicoglu MS; Aydin T
    Turk Neurosurg; 2019; 29(5):683-688. PubMed ID: 31192441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.